A study to test how different doses of BI 3814916 are tolerated by healthy people
1543-0001
Phase 1 other active
Quick answer
A study to test how different doses of BI 3814916 are tolerated by healthy people for healthy volunteer trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- healthy volunteer trial
- Phase
- Phase 1
- Modality
- other
- Status
- active